BCRF talks to Dr. Kenneth Offit about how these mutations affect men’s health and risk of cancer
Key Takeaways
Many of us are familiar with the BRCA1 and BRCA2 genes that, when mutated, are linked to an increased risk of breast cancer in women. But less often discussed is how BRCA gene mutations (and other, less-commonly known gene mutations) can affect men.
When a man carries a cancer susceptibility gene mutation, he has a higher risk of developing breast, prostate, and other cancers, as well as the same 50 percent chance of passing that mutation on to his children as women. Despite these facts, when people think of their family history of breast cancer, they may only consider only their mother’s side of the family tree.
In honor of Men’s Health Week in June, we spoke with BCRF investigator Dr. Kenneth Offit, chief of the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center, to discuss inherited gene mutations and hereditary cancers in men. Watch the full video above or read on below.
At the Clinical Genetics Service at Memorial Sloan Kettering Cancer Center, we see family members—men, women, and children—of patients who are at risk for hereditary cancers. Over the last 20 years, we've discovered a lot of the pathways that increase cancer risk in families, and so we've been providing genetic testing for patients with cancer and their family members for decades. We conduct the testing, give folks the results, and then advise as to what could be done for prevention, detection, and sometimes treatment. We also carry out research.
One of the things we're always quick to point out is that all of us have BRCA genes. They're very important. It's only when you have mutations of these genes that they increase cancer risk. What these genes normally do is they help cells decide how to grow and regulate themselves. But if you happen to be born with a mutation in one of those genes, then the cells grow and divide in an abnormal way, and you may develop cancer.
There are other genes whose names that are not as common, like PALB2, CHEK2, and ATM. These cause breast cancer in men and women, too. We also see hereditary cancers of other sites—the uterus and the ovaries—in women. In men and women, the colon, the thyroid, the stomach, and the pancreas are all sites of inherited cancers that are caused by mutations in normal growth regulatory genes.
For men, there is a risk of breast cancer, but it’s rare. Having a BRCA gene mutation increases your cancer risk, most significantly for prostate cancer and more so than breast cancer.
Yes, and all of genetics is ancestry. In the general population of men and women, around one in 400 people will carry a BRCA gene mutation. In certain populations in the world, that risk can be 10 times higher—one in 40.
My team and I discovered the most common mutation in the Ashkenazi/Eastern European Jews. These men had a higher risk of prostate cancers and aggressive prostate cancers. We also see a very high rate of these mutations in other groups that have been isolated geographically. Scandinavian countries are an example. We have these mutations in Iceland, Finland, and Norway, and some of them occur as commonly as they do in Ashkenazi Jews. Then we also have mutations that are common in other parts of the world that we sometimes see in the United States. For example, there's a particularly common BRCA1 mutation in Poland. We then see it in Chicago, because of the city’s high population of individuals of Polish ancestry.
These mutations happen when populations are isolated. This could be because they're literally on islands, like in the Scandinavian countries. Or, in the case of Eastern European Jews, the isolation was tied to persecution and a limiting of the area where they could live—an island defined by armies rather than by oceans.
One of the great misconceptions about the male connection with BRCA mutations is that one only looks to the mother's side of the family—you’re only thinking of your mother's history of cancer, your aunt’s, your sister’s. But, in fact, a BRCA gene mutation can come from either side. Fifty percent of the time it's from your father, and 50 percent of the time it's from your mother.
Some of the most challenging family histories that we see are those where a woman will come in and say, “I have no family history,” or a man will come in with a prostate cancer and a BRCA mutation and say, “I don't have a family history.” Very often these mutations will come from the father, and they may just not have seen it.
We're at an inflection point where we don’t yet recommend that everybody just get screened. But I happen to believe, for example, that all men (and women) who are of Eastern European Jewish ancestry should be tested. That’s something that we're in the process of proving is safe through our BCRF-supported study. Outside of one of those ancestries I mentioned that have a high risk, we have to just rely on family history pointing you in the direction of getting tested.
A man’s risk of getting breast cancer is exceedingly low—one in 1,000, compared to one in eight for women. So, we don't do routine breast cancer screening for men. But, for men who have a BRCA mutation, their chance of getting a breast cancer increases quite substantially to as much as one in 20. If you're in that group where you have that lifetime risk, what can you do? We recommend these men start doing breast self-exams starting at age 35. I tell my patients to pat their chests in the shower in the morning. In men, it's very easy to feel a little nodule.
And then, of course, we mentioned prostate cancer risk in men, and we have a blood test for that: the prostate-specific antigen (PSA). It's controversial to some, but not, I think, in this setting. We recommend that for men with BRCA mutations, and, in fact, we even have a different threshold for what's considered normal in BRCA mutation carriers. From there, we do biopsies and find these prostate cancers at the early, curable stage.
BRCA mutation testing for men typically begins with a consultation with a genetic counselor or healthcare provider to review personal and family cancer history and determine whether testing is appropriate. The test itself involves either a blood draw or a saliva sample, which is then analyzed in a certified laboratory for mutations in the BRCA1 and BRCA2 genes.Results are generally available within a few weeks. A healthcare professional will review the results with you to explain their meaning, discuss cancer risks, and recommend next steps—such as additional screening, preventive strategies, or genetic testing for family members.BCRF-funded research has helped expand our understanding of how BRCA mutations affect men, improving testing guidelines and risk management recommendations.
Currently, there is no routine schedule for BRCA mutation testing in men. Most experts recommend testing once, ideally when there is a strong family history of breast, ovarian, pancreatic, or prostate cancer, or when an individual has Ashkenazi Jewish ancestry, which is associated with higher rates of BRCA mutations.While testing is not universal, research supported by BCRF continues to explore the value of broader genetic screening and its potential to improve early detection and prevention in men. Until guidelines evolve, men should discuss their family history and potential risk factors with a genetic counselor or healthcare provider to determine whether testing is appropriate.
Support BCRF’s groundbreaking research uncovering how BRCA mutations affect men and women—and help fuel the next genetic breakthrough.
Support research with a legacy gift. Sample, non-binding bequest language:
I give to the Breast Cancer Research Foundation, located in New York, NY, federal tax identification number 13-3727250, ________% of my total estate (or $_____).
Stay in the know with the latest research news, insights, and resources delivered to your inbox.
Follow BCRF on all the major platforms for research news, inspiring stories, and more.